Abbott begins clinical trial of new drug-eluting resorbable scaffold

Abbott’s Esprit BTK System is a semi-crystalline bioresorbable polymer developed to prevent vessel recoil and offer a platform for drug delivery. Credit: Scientific Animations.



  • Abbott